13.157 hasil
Menampilkan 1–20 · 0,57 detik · RSS
Haematologica
Scopus
ISSN 0390-6078 · Ferrata Storti Foundation · 13.157 artikel di indeks
-
Artikel Jurnal Teks lengkap
Mmrn1 expression defines a novel subset of hematopoietic stem cells and leukemia stem cells with great self-renewal potential
Hematopoietic stem cells (HSCs) are critical for lifelong blood cell generation. After mutation accumulation and functional disruption, HSCs may transform into leukemic stem cells (LSCs), leading to malignant hematological disorders. However, both HSCs and LSCs are highly heterogeneous, which…
-
Artikel Jurnal Teks lengkap
Morphologic and immunophenotypic characterization of lymphocytosis following BCMAtargeted CAR-T cell therapy in relapsed/refractory multiple myeloma
Not available.
-
Artikel Jurnal Teks lengkap
Single-cell dissection of plasma cell clonal evolution to smoldering multiple myeloma after CD19 CAR-T cell therapy in B-cell acute lymphoblastic leukemia
Not available.
-
Artikel Jurnal Teks lengkap
A lower-intensity, venetoclax-containing protocol is effective in adults with newly diagnosed mixed-phenotype acute leukemia
Not available.
-
Artikel Jurnal Teks lengkap
Multicenter prospective phase II study of decitabine priming with low-dose idarubicin, cytarabine, and G-CSF in children with refractory or relapsed acute myeloid leukemia
No standard salvage regimen exists for relapsed/refractory (R/R) pediatric AML. In this prospective, multicenter Phase II trial, 101 evaluable patients (
-
Artikel Jurnal Teks lengkap
Preserving thrombosis and life years in polycythemia vera: start by reading the biology of the disease
The Swedish nationwide study by Leontyeva et al. (Haematologica, sept, 2025) revealed that patients with myeloproliferative neoplasms (MPN) continue to lose life years compared with the general population, with polycythemia vera (PV) showing a 1.8-year loss in restricted mean survival at 15 years…
-
Artikel Jurnal Teks lengkap
Interleukin signaling mitigates the inhibitory effects of combined Src/BCR-ABL1 blockade on T-cell activity in Philadelphia chromosome-positive acute lymphoblastic leukemia
Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), driven by the BCR-ABL1 fusion gene, remains a high-risk malignancy despite therapeutic advances. Tyrosine kinase inhibitors (TKIs) targeting BCR-ABL1 have significantly improved outcomes, but resistance and relapse persist…
-
Artikel Jurnal Teks lengkap
Post-CAR-T lymphocytosis in multiple myeloma: too much of a good thing?
Not available.
-
Artikel Jurnal Teks lengkap
Male sex adversely impacts survival and myeloid malignancy risk in MGUS: a real-world population-based study
Monoclonal gammopathy of undetermined significance (MGUS) is a common plasma cell disorder with well described risks of progression to myeloma and lymphoplasmacytic lymphoma. Using data from an established UK population-based cohort of haematological malignancies and premalignancies, we…
-
Artikel Jurnal Teks lengkap
Chronic graft-versus-host disease in the era of post-transplant cyclophosphamide
Chronic graft-versus-host disease (cGVHD) remains a leading cause of late morbidity after allogeneic hematopoietic cell transplantation (HCT), but its phenotype under modern prophylaxis with post-transplant cyclophosphamide (PTCy) is not well characterized. We conducted a prospective, single-center…
-
Artikel Jurnal Teks lengkap
Common ancestral origin of indeterminate dendritic cell tumor and chronic myelomonocytic leukemia in clonal hematopoiesis
Not available.
-
Artikel Jurnal Teks lengkap
Rethinking the effectiveness of hypomethylating agents in myelodysplastic syndromes: the 50%-2-year wall
Not available.
-
Artikel Jurnal Teks lengkap
ICANS mitigation in high-risk elderly patients treated with CD28 co-stimulatory anti-CD19 CAR-T cells using a standardization protocol: a pilot study
CAR-T has transformed relapsed/refractory LBCL treatment, with CD28-based products yielding rapid responses but higher ICANS rates. With Axicabtagene-ciloleucel and Brexucabtagene-autoleucel, overall and severe ICANS reach 78% and 35%, respectively. Older adults are vulnerable, yet mitigation…
-
Artikel Jurnal Teks lengkap
Sequential therapy with allogeneic HCT in patients aged ≥70 years with active AML: a singlecenter retrospective analysis
Patients ≥ 70 years with relapsed/refractory acute myeloid leukemia (AML) have an extremely poor prognosis. we adopted a sequential therapy approach, aiming to proceed directly to allogeneic hematopoietic cell transplantation (HCT) despite active disease. We analyzed results of all consecutive…
-
Artikel Jurnal
Clonal hematopoiesis driver mutations: molecular mechanisms and clinical implications - inclusive fitness of pre-leukemic hematopoietic stem and progenitor cells through pro-inflammatory features of their progeny
Clonal hematopoiesis (CH) is driven by the age-associated expansion of hematopoietic stem and progenitor cells (HSPCs) that harbor somatic driver mutations; however, the mechanisms underlying their long-term persistence remain incompletely understood. This review frames CH through the lens of…
-
Artikel Jurnal
Hematologic complications in patients exposed to poly-ADP ribose polymerase inhibitors
Not available.
Menampilkan maksimal 50 halaman. Persempit pencarian dengan filter untuk hasil yang lebih spesifik.